info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

Menu

  Submit Manuscript

OpinionOpen Access

Olfactory Test Contributions in the Diagnosis and Follow-Up of MCI and MA Patients

Volume 9 - Issue 1

Magali Payne1,2,3, Marilou Serris3,4, Renaud David1,2 and Auriane Gros1,3,5*

  • Author Information Open or Close
    • 1Cognition Behaviour Technology CoBTeK - lab, University Côte d’Azur, France
    • 2Memory Center - CMRR, CHU Nice , France
    • 3Dépt of speech therapy , University Côte d’Azur, France
    • 4Nice University Institute of Face and Neck, CHU Nice , France
    • 5Nice University of Medicine, France

    *Corresponding author: Auriane Gros, Cognition Behaviour Technology (CoBTeK) laboratory, Speech Therapy Department of Nice, Nice University of Medicine, France

Received: September 10, 2018;   Published: September 12, 2018

DOI: 10.26717/BJSTR.2018.09.001730

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

To prevent earlier AD, the olfactory test could be used as a non-invasive and non-expensive tool. To do so we propose to bring together professional of the recommendations and use them to create a specific tool.

Keywords: Alzheimer’s Disease; Olfactory test

Abstract | Introduction | References |

Track Your Article

Member In


View More
Newsletter

Archive


News & Events

  • Submissions are now open for NEXT ISSUE (VOLUME 58 – ISSUE 3), AUGUST – 2024 Submit Now

Subject Area

e-books

Reprints

Video Articles